drugset

drugset / Trial / NCT00311038

Pilot Study of ONO-1101 in Patients Scheduled for Multi-slice CT

NCT00311038 ↗

Phase 2 Completed 90 enrolled Ono Pharmaceutical Co., Ltd.

Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for multi-slice CT.

Timeline

Start: 2006-04
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Landiolol	Small molecule	—	—

Indications